Alzheimer’s/Dementia

Largest Alzheimer’s genetic database soon to open for researchers, investigators

The portal for the National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (NIAGADS) is currently undergoing beta testing involving a small number of investigators, with broader access slated to begin next month.

Read More >>

Fewer people with mental decline are seeing doctors, panel states

Though mental decline can be an uncomfortable topic for patients and their doctors, the panel says family physicians should do a thorough evaluation when concerning symptoms arise and share the diagnosis candidly.

Read More >>

Nearly 100 Alzheimer’s drugs in final development stages

A new report from top researchers says the number of drugs advancing through clinical phase two and phase three trials provides reason to believe that breakthroughs may be in the current pharmaceutical pipeline.

Read More >>

Bill Gates joins coalition to fund Alzheimer’s research

Besides a cure, what do those afraid of Alzheimer’s disease need most? According to entrepreneur and philanthropist Bill Gates, a key need is a “reliable, affordable, and accessible” diagnostic test.

Read More >>

Study connects Alzheimer’s with high blood pressure

Keep an eye out on your blood pressure because scientists just discovered that higher blood pressure in the elderly increases the risks of Alzheimer's disease.

Read More >>

Nursing homes take part in National Alzheimer’s Poetry Project

On Tuesday morning, 16 residents gathered in a circle along with several staff members while the founder of the Alzheimer’s Poetry Project, Gary Glazner, recited poems in a repeat-after-me format.

Read More >>

Georgia institute to begin “Dealing with Dementia” training

Caregivers of people with dementia have access to training that makes life a little easier thanks to a new program offered through Big Bend Hospice Inc.

Read More >>

Biogen sees positive results in Alzheimer’s trial, shares

Biogen Inc. shares surged more than 18% Friday after the biotechnology company and Tokyo-based Eisai Co. Ltd. announced positive results from a mid-stage trial of a treatment for Alzheimer’s disease.

Read More >>

Study connects dementia and chronic inflammation

Heightened levels of brain inflammation biomarkers have been linked to the development of dementia, but it remains unclear whether inflammation must be present long-term in order to affect brain health.

 

 

 
Read More >>

Alzheimer’s Association should see healthy amount of proposed $401 million funding increase

The Alzheimer’s Association, its advocacy arm the Alzheimer’s Impact Movement and its nationwide network of advocates are celebrating another proposed funding increase for Alzheimer’s and dementia research at the National Institutes of Health.

Read More >>